Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Clinical trial

Comparison of the Effecta and Drawbacks of Heparin Versus Hirudin Drugs in Haemodialysis Patients in Assiut University Hospitals

ID
Name
heparin and herodin in HD
Description
The goal of this study is to compare the efficacy and drawbacks of Heparin and Hirudin in Haemodialysis patients. The main question it aims to answer is: which drug is more safe in Haemodialysis?
Trial arms
Trial start
2023-12-20
Estimated PCD
2025-09-01
Trial end
2026-09-01
Status
Not yet recruiting
Phase
Early phase I
Treatment
Heparin
Comparison between heparin and hirudin
Arms:
Heparin and Hirudin
Other names:
Hirudin
Size
98
Primary endpoint
Number of bleeding events and efficacy of dialysis during dialysis
Baseline
Eligibility criteria
Inclusion Criteria: 1. patient age between 18:70 2. Haemodialysis duration less than 6 months 3. Agree to participate in the study Exclusion Criteria: 1. AKI 2. patients with impaired coagulation profile 3. Decompensated liver disease
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['EARLY_PHASE1'], 'designInfo': {'allocation': 'NA', 'interventionModel': 'SINGLE_GROUP', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'NONE'}}, 'enrollmentInfo': {'count': 98, 'type': 'ESTIMATED'}}
Updated at
2023-11-21

1 organization

1 product

1 indication

Organization
Basma Rabiey
Product
Heparin
Indication
Hemodialysis